<DOC>
	<DOCNO>NCT00457626</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability long-term use ( 18 week ) valsartan child 6 month 5 year old hypertension .</brief_summary>
	<brief_title>An Open Label Extension Study Evaluate Long-term Use Valsartan Children 6 Months 5 Years Old With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Inclusion criterion Patients qualify enter core study . Patients participate core study , complete period 1 rerandomized period 2 continue least 3 day period 2 . Exclusion criterion Patients complete period 1 core study . Patients rerandomized period 2 core study continue = &gt; 3 day period 2 core study . Patients experienced adverse event consider serious drug relate core study . Patients exclude core study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Children</keyword>
	<keyword>pediatrics</keyword>
	<keyword>High Blood Pressure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Valsartan</keyword>
</DOC>